{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T20:30:17Z","timestamp":1770323417721,"version":"3.49.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.vaccine.2009.09.126","type":"journal-article","created":{"date-parts":[[2009,10,13]],"date-time":"2009-10-13T08:53:02Z","timestamp":1255423982000},"page":"38-47","source":"Crossref","is-referenced-by-count":46,"title":["Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development"],"prefix":"10.1016","volume":"28","author":[{"given":"Kenneth L.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inna G.","family":"Ovsyannikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"H. Robert","family":"Bergen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Poland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2009.09.126_bib1","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/sj.clpt.6100415","article-title":"Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics","volume":"82","author":"Poland","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"15","key":"10.1016\/j.vaccine.2009.09.126_bib2","doi-asserted-by":"crossref","first-page":"10618","DOI":"10.1074\/jbc.M510511200","article-title":"Structural definition of the H-2Kd peptide-binding motif","volume":"281","author":"Mitaksov","year":"2006","journal-title":"J Biol Chem"},{"issue":"6139","key":"10.1016\/j.vaccine.2009.09.126_bib3","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/329506a0","article-title":"Structure of the human class I histocompatibility antigen, HLA-A2","volume":"329","author":"Bjorkman","year":"1987","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.126_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2249.2007.03401.x","article-title":"Long-term T cell memory to human leukocyte antigen-A2 supertype epitopes in humans vaccinated against smallpox","volume":"149","author":"Ostrout","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.126_bib5","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.4049\/jimmunol.179.2.1303","article-title":"Human cytotoxic CD4+ T cells recognize HLA-DR1-restricted epitopes on vaccinia virus proteins A24R and D1R conserved among poxviruses","volume":"179","author":"Mitra-Kaushik","year":"2007","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.09.126_bib6","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.4049\/jimmunol.175.8.5504","article-title":"HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products","volume":"175","author":"Pasquetto","year":"2005","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.126_bib7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1086\/518794","article-title":"The immunogenetics of smallpox vaccination","volume":"196","author":"Stanley","year":"2007","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2009.09.126_bib8","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0198-8859(01)00319-6","article-title":"Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules","volume":"62","author":"Sidney","year":"2001","journal-title":"Hum Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.09.126_bib9","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.4049\/jimmunol.157.8.3480","article-title":"Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules","volume":"157","author":"Sidney","year":"1996","journal-title":"J Immunol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2009.09.126_bib10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s002510050594","article-title":"Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism","volume":"50","author":"Sette","year":"1999","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2009.09.126_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1073\/pnas.262668999","article-title":"Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines","volume":"100","author":"Drexler","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"39","key":"10.1016\/j.vaccine.2009.09.126_bib12","doi-asserted-by":"crossref","first-page":"13980","DOI":"10.1073\/pnas.0506768102","article-title":"HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation","volume":"102","author":"Oseroff","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.vaccine.2009.09.126_bib13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nbt1215","article-title":"A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus","volume":"24","author":"Moutaftsi","year":"2006","journal-title":"Nat Biotechnol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.09.126_bib14","doi-asserted-by":"crossref","first-page":"7890","DOI":"10.4049\/jimmunol.178.12.7890","article-title":"A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection","volume":"178","author":"Assarsson","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.09.126_bib15","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1126\/science.1546328","article-title":"Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry","volume":"255","author":"Hunt","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2009.09.126_bib16","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1021\/ac9801014","article-title":"A microcapillary column switching HPLC-electrospray ionization MS system for the direct identification of peptides presented by major histocompatibility complex class I molecules","volume":"70","author":"van der Heeft","year":"1998","journal-title":"Anal Chem"},{"key":"10.1016\/j.vaccine.2009.09.126_bib17","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1016\/S0264-410X(00)00505-3","article-title":"The role of mass spectrometry in vaccine development","volume":"19","author":"Poland","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.126_bib18","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.4049\/jimmunol.174.9.5636","article-title":"Mass tag-assisted identification of naturally processed HLA class II-presented meningococcal peptides recognized by CD4+ lymphocytes","volume":"174","author":"Meiring","year":"2005","journal-title":"J Immunol"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2009.09.126_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijms.2006.08.009","article-title":"The contributions of mass spectrometry to understanding of immune recognition by T lymphocytes","volume":"259","author":"Engelhard","year":"2007","journal-title":"Int J Mass Spectrom"},{"issue":"6","key":"10.1016\/j.vaccine.2009.09.126_bib20","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/sj.clpt.6100389","article-title":"Mass spectrometry and peptide-based vaccine development","volume":"82","author":"Ovsyannikova","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.vaccine.2009.09.126_bib21","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1002\/1521-4141(2000)30:8<2216::AID-IMMU2216>3.0.CO;2-7","article-title":"Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach","volume":"30","author":"Schirle","year":"2000","journal-title":"Eur J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.09.126_bib22","first-page":"4072","article-title":"A MAGE-A1 HLA-A A*0201 epitope identified by mass spectrometry","volume":"61","author":"Pascolo","year":"2001","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.vaccine.2009.09.126_bib23","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/intimm\/dxn102","article-title":"Mass spectrometric identification of an HLA-A*0201 epitope from Plasmodium falciparum MSP-1","volume":"20","author":"Carralot","year":"2008","journal-title":"Int Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.126_bib24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1128\/JVI.78.1.42-51.2004","article-title":"Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides","volume":"78","author":"Ovsyannikova","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.09.126_bib25","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1021\/pr0501416","article-title":"Identification of class II HLA-DRB1*03-bound measles virus peptides by 2D-liquid chromatography tandem mass spectrometry","volume":"4","author":"Johnson","year":"2005","journal-title":"J Proteome Res"},{"key":"10.1016\/j.vaccine.2009.09.126_bib26","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1172\/JCI118450","article-title":"Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytes","volume":"97","author":"Tsai","year":"1996","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.126_bib27","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1074\/mcp.T500014-MCP200","article-title":"Stable isotope tagging of epitopes: a highly selective strategy for the identification of major histocompatibility complex class I-associated peptides induced upon viral infection","volume":"5","author":"Meiring","year":"2006","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.vaccine.2009.09.126_bib28","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.4049\/jimmunol.150.7.2955","article-title":"Recognition of human melanoma cells by HLA-A2.1-restricted cytotoxic T lymphocytes is mediated by at least six shared peptide epitopes","volume":"150","author":"Slingluff","year":"1993","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2009.09.126_bib29","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.jasms.2005.07.015","article-title":"Accurate mass precursor ion data and tandem mass spectrometry identify a class I Human Leukocyte Antigen A*0201-presented peptide originating from vaccinia virus","volume":"16","author":"Johnson","year":"2005","journal-title":"J Am Soc Mass Spectrom"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.126_bib30","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4049\/jimmunol.123.1.342","article-title":"Use of a monoclonal antibody (W6\/32) in structural studies of HLA-A,B,C, antigens","volume":"123","author":"Parham","year":"1979","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.126_bib31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00262-004-0592-y","article-title":"Use of selected reaction monitoring mass spectrometry for the detection of specific MHC class I peptide antigens on A3 supertype family members","volume":"54","author":"Hogan","year":"2005","journal-title":"Cancer Immunol Immunother"},{"issue":"20","key":"10.1016\/j.vaccine.2009.09.126_bib32","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1021\/ac025747h","article-title":"Empirical statistical model to estimate the accuracy of peptide identifications made by MS\/MS and database search","volume":"74","author":"Keller","year":"2002","journal-title":"Anal Chem"},{"issue":"17","key":"10.1016\/j.vaccine.2009.09.126_bib33","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1021\/ac0341261","article-title":"A statistical model for identifying proteins by tandem mass spectrometry","volume":"75","author":"Nesvizhskii","year":"2003","journal-title":"Anal Chem"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.126_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nmeth1019","article-title":"Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry","volume":"4","author":"Elias","year":"2007","journal-title":"Nat Methods"},{"issue":"12","key":"10.1016\/j.vaccine.2009.09.126_bib35","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1074\/mcp.T500030-MCP200","article-title":"Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap","volume":"4","author":"Olsen","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.vaccine.2009.09.126_bib36","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF00172063","article-title":"MHC ligands and peptide motifs: first listing","volume":"41","author":"Rammensee","year":"1995","journal-title":"Immunogenetics"},{"issue":"8","key":"10.1016\/j.vaccine.2009.09.126_bib37","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/eji.1830070816","article-title":"Molecular structure of human histocompatibility antigens: the HLA-C series","volume":"7","author":"Snary","year":"1977","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.126_bib38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4049\/jimmunol.160.1.171","article-title":"Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction","volume":"160","author":"Neisig","year":"1998","journal-title":"J Immunol"},{"issue":"52","key":"10.1016\/j.vaccine.2009.09.126_bib39","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.1016\/j.vaccine.2007.10.040","article-title":"Genomic differences of Vaccinia virus clones from Dryvax smallpox vaccine: the Dryvax-like ACAM2000 and the mouse neurovirulent Clone-3","volume":"25","author":"Osborne","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.126_bib40","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1034\/j.1399-0039.2003.00112.x","article-title":"Sensitive quantitative predictions of peptide-MHC binding by a \u2018Query by Committee\u2019 artificial neural network approach","volume":"62","author":"Buus","year":"2003","journal-title":"Tissue Antigens"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.126_bib41","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1110\/ps.0239403","article-title":"Reliable prediction of T-cell epitopes using neural networks with novel sequence representations","volume":"12","author":"Nielsen","year":"2003","journal-title":"Protein Sci"},{"key":"10.1016\/j.vaccine.2009.09.126_bib42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4049\/jimmunol.152.1.163","article-title":"Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains","volume":"152","author":"Parker","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.09.126_bib43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002510050595","article-title":"SYFPEITHI: database for MHC ligands and peptide motifs","volume":"50","author":"Rammensee","year":"1999","journal-title":"Immunogenetics"},{"issue":"6","key":"10.1016\/j.vaccine.2009.09.126_bib44","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nri2092","article-title":"Integrating epitope data into the emerging web of biomedical knowledge resources","volume":"7","author":"Peters","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2009.09.126_bib45","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1542\/peds.55.3.342","article-title":"Smallpox vaccination reactions, prophylaxis, and therapy of complications","volume":"55","author":"Goldstein","year":"1975","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2009.09.126_bib46","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1001\/jama.289.24.3283","article-title":"Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel","volume":"289","author":"Halsell","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2009.09.126_bib47","doi-asserted-by":"crossref","unstructured":"Poland GA, Neff JM. Smallpox vaccines: problems and prospects. In: Poland GA, guest editor. Immunology and Allergy Clinics of North America: vaccines in the 21st century. Philadelphia: WB Saunders Company; 2003; p. 731\u201343.","DOI":"10.1016\/S0889-8561(03)00096-1"},{"issue":"RR-14","key":"10.1016\/j.vaccine.2009.09.126_bib48","first-page":"1","article-title":"Recommendations of the Immunization Practices Advisory Committee (ACIP)","volume":"40","author":"Vaccinia (smallpox) vaccine","year":"1991","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.126_bib49","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/viro.1998.9123","article-title":"The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses","volume":"244","author":"Antoine","year":"1998","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.126_bib50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/rmv.527","article-title":"T-cell epitope discovery for variola and vaccinia viruses","volume":"17","author":"Kennedy","year":"2006","journal-title":"Rev Med Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.09.126_bib51","doi-asserted-by":"crossref","first-page":"8431","DOI":"10.4049\/jimmunol.175.12.8431","article-title":"Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara","volume":"175","author":"Smith","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.09.126_bib52","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1099\/0022-1317-74-4-751","article-title":"Class I major histocompatibility complex-restricted cytotoxic T cell responses to vaccinia virus in humans","volume":"74","author":"Erickson","year":"1993","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2009.09.126_bib53","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/513968","article-title":"Immunologic responses to vaccinia vaccines administered by different parenteral routes","volume":"175","author":"McClain","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.126_bib54","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1128\/JVI.70.4.2627-2631.1996","article-title":"Human cytotoxic T-cell memory: long-lived responses to vaccinia virus","volume":"70","author":"Demkowicz","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.09.126_bib55","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/380906","article-title":"Dose-dependent neutralizing-antibody responses to vaccinia","volume":"189","author":"Belshe","year":"2004","journal-title":"J Infect Dis"},{"issue":"16","key":"10.1016\/j.vaccine.2009.09.126_bib56","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses","volume":"100","author":"Belyakov","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.09.126_bib57","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1034\/j.1600-065X.2002.18815.x","article-title":"Towards patient-specific tumor antigen selection for vaccination","volume":"188","author":"Rammensee","year":"2002","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.vaccine.2009.09.126_bib58","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1586\/14789450.3.6.653","article-title":"Contribution of mass spectrometry-based proteomics to immunology","volume":"3","author":"Hillen","year":"2006","journal-title":"Expert Rev Proteomics"},{"issue":"9","key":"10.1016\/j.vaccine.2009.09.126_bib59","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/sj.leu.2404787","article-title":"Identification of T-cell epitopes for cancer immunotherapy","volume":"21","author":"Kessler","year":"2007","journal-title":"Leukemia"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09014868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09014868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T04:30:08Z","timestamp":1685161808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09014868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0264410X09014868"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.09.126","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}